Financial Gravity Asset Management, Inc. Abbott Laboratories Transaction History

Financial Gravity Asset Management, Inc.

$459 Billion
Q1 2025

A detailed history of Financial Gravity Asset Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Financial Gravity Asset Management, Inc. holds 160 shares of ABT stock, worth $21,123. This represents 0.0% of its overall portfolio holdings.

Number of Shares

160

Previous 5,680 97.18%

Holding current value

$21,123

Previous $590 Million 96.4%

% of portfolio

0.0%

Previous 0.15%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	SELL	$111.1 - $140.22 $613,272 - $774,014	-5,520 Reduced 97.18%	160 $21.2 Million
Q2 2024 Aug 06, 2024	BUY	$100.73 - $112.44 $539,912 - $602,678	5,360 Added 1675.0%	5,680 $590 Million
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $99,882 - $110,315	912 Added 18.91%	5,736 $652 Million
Q4 2023 Jun 26, 2024	SELL	$90.19 - $110.4 $488,469 - $597,926	-5,416 Reduced 94.42%	320 $35.2 Million
Q3 2023 Nov 15, 2023	BUY	$95.53 - $114.62 $435,425 - $522,437	4,558 Added 1713.53%	4,824 $467,000
Q2 2023 Aug 08, 2023	BUY	$100.78 - $112.29 $806 - $898	8 Added 3.1%	266 $3.9 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $14,335 - $16,873	148 Added 134.55%	258 $316,000
Q4 2022 Feb 15, 2023	SELL	$95.06 - $111.52 $44,868 - $52,637	-472 Reduced 81.1%	110 $3.1 Million
Q3 2022 Nov 03, 2022	SELL	$96.76 - $112.03 $6,966 - $8,066	-72 Reduced 11.01%	582 $276,000
Q2 2022 Aug 05, 2022	SELL	$102.07 - $123.37 $8,880 - $10,733	-87 Reduced 11.74%	654 $310,000
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $18,813 - $22,941	-165 Reduced 18.21%	741 $343,000
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $97,391 - $119,250	843 Added 1338.1%	906 $409,000
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $8,399 - $9,292	-72 Reduced 53.33%	63 $125,000
Q2 2021 Aug 11, 2021	SELL	$105.79 - $124.53 $423 - $498	-4 Reduced 2.88%	135 $131,000
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $9,904 - $11,668	-91 Reduced 39.57%	139 $798,000
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $24,150 - $26,316	230 New	230 $25,000
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $90,658 - $116,032	-1,184 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$62.82 - $91.86 $68,725 - $100,494	-1,094 Reduced 48.02%	1,184 $93,000
Q4 2019 Feb 28, 2020	SELL	$78.51 - $87.4 $72,700 - $80,932	-926 Reduced 28.9%	2,278 $198,000
Q3 2019 Oct 15, 2019	SELL	$81.84 - $88.74 $156,887 - $170,114	-1,917 Reduced 37.43%	3,204 $268,000
Q2 2019 Jul 26, 2019	BUY	$72.88 - $85.0 $220,607 - $257,295	3,027 Added 144.56%	5,121 $431,000
Q1 2019 Apr 19, 2019	BUY	$66.22 - $80.06 $90,787 - $109,762	1,371 Added 189.63%	2,094 $167,000
Q3 2018 Oct 31, 2018	SELL	$60.81 - $73.36 $59,168 - $71,379	-973 Reduced 57.37%	723 $49,000
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $95,508 - $105,412	1,659 Added 4483.78%	1,696 $109,000
Q1 2018 May 23, 2018	BUY	$56.27 - $63.62 $2,081 - $2,353	37 New	37 $2,000

Others Institutions Holding ABT

# of Institutions

3,541

Shares Held

1.38B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $231B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.

Account

Financial Gravity Asset Management, Inc. Abbott Laboratories Transaction History